DR. ROGER ALAN WAGNER, MD, PHD
Osteopathic Medicine at Pasteur Dr, Palo Alto, CA
License number
California A73669
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
California 36853
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 736-0640
Professional information
Roger Alan Wagner, Stanford CA
Specialties:
Internal Medicine, Cardiovascular Disease
Work:
Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Colorado (1994)
Dr. Roger A Wagner, Stanford CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Stanford Office
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone), (650) 725-8950 (Fax)
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone), (650) 725-8950 (Fax)
Languages:
English
Hospitals:
Stanford Office
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University of Colorado At Denver
Graduated: 1994
Stanford University Hospital
University Of Co School Of Med
University of Colorado At Denver
Graduated: 1994
Stanford University Hospital
University Of Co School Of Med
Cardiac Pressure Overload Associated Genes
US Patent:
2006009, May 4, 2006
Filed:
Sep 20, 2005
Appl. No.:
11/231700
Inventors:
Roger Wagner - Stanford CA, US
Raymond Tabibiazar - Stanford CA, US
Thomas Quertermous - Stanford CA, US
Raymond Tabibiazar - Stanford CA, US
Thomas Quertermous - Stanford CA, US
International Classification:
C12Q 1/68, G01N 33/53, C12M 1/34
US Classification:
435006000, 435007100, 435287200
Abstract:
The present invention identifies genes whose gene products are differentially expressed pressure overload of the heart. The invention provides methods for diagnosing or assessing an individual's susceptibility to heart failure from many etiologies, as well as the presence and severity of hypertrophy, chamber enlargement, or systolic heat failure. Also provided are therapeutic methods for treating a heart patient or methods for prophylactically treating an individual susceptible to heart failure. Additionally, the invention describes screening methods for identifying agents that can be administered to treat individuals that have suffered a heart attack or are at risk of heart failure.